Bluebird Bio Investor

Balderton Capital is a Series A-focused European venture capital firm.
Founded in 2000, Balderton backs breakthrough technology businesses. The company is headquartered in London, England. Balderton Capital includes the founders and operational leaders of multi-billion dollar global companies.
Balderton Capital is committed to putting expertise, support, and network, to work for founders. Balderton Capital is sharing expertise and insights to help go through the journey from an idea to the large, global and impactful business you aim to build.

Invests into
Industry: Personalized Medicine
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 1992
Employees Number: 51-100
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
info@bluebirdbio.com
@bluebirdbio
Register and Claim Ownership